To ask the Secretary of State for Health and Social Care, whether the Government has made an assessment of the potential merits of allocating funding to research into the development of a national screening programme for kidney cancer; and if he will make a statement.
The UK National Screening Committee (UK NSC) advises ministers and the National Health Service in all four nations about all aspects of screening policy and supports implementation. Using research evidence, pilot programmes and economic evaluation, it assesses the evidence for programmes against a set of internationally recognised criteria.
The UK NSC has not reviewed the evidence for a national screening programme for kidney cancer. Therefore an assessment of the potential merits of allocating funding for research has not been made.
Nevertheless, Public Health England has funded a Be Clear on Cancer ‘Blood in pee’ campaign which ran across England from July to September 2018, which aimed to raise awareness and improve early diagnosis of bladder and kidney cancer.
The NHS Long Term Plan, published on 7 January, sets out a comprehensive package of measures that will transform cancer diagnosis and treatment across the country over the next 10 years; a decade in which patients can expect to see huge improvements in the prevention, diagnosis and treatment of cancer. The aim is to see 55,000 more people surviving cancer for five years in England each year from 2028.